Close menu




January 4th, 2021 | 11:12 CET

NIO, Fokus Mining, TUI - Off to new heights!

  • Investments
Photo credits: pixabay.com

There were records upon records set in one of the most exciting stockmarket years, 2020. Both the DAX, Dow and the technology exchange Nasdaq jumped to new highs. The leading cryptocurrency Bitcoin started an incredible comeback and raced through its 2017 high to now USD 34,000.00. Records will tumble again in 2021. Cryptocurrencies and hydrogen and electric cars will continue to be in demand, but highs in other areas are also possible.

time to read: 2 minutes | Author: Stefan Feulner
ISIN: CA3442041024 , US62914V1061 , DE000TUAG000

Table of contents:


    The shine is coming back

    Gold also managed to climb to a new all-time high of USD 2,063.01 on August 6, 2020. After that, however, the precious yellow metal switched to correction mode. Due to the burgeoning hope of an imminent end of the Corona pandemic, the positive test results of several Covid vaccines, and the Trump administration's deselection, gold temporarily fell below the critical support level of USD 1,800.00, which, however, was dynamically recovered.

    Currently, the price is quoted at just below USD 1,900.00. An overcoming of the downward trend formed since August at currently 1,907.00 points would trigger a further bullish signal in the direction of USD 1,960.00. In the long term, we expect further rising prices and new highs. The global uncertainties and the States ever-increasing debt burdens speak for an investment in gold and gold mining stocks.

    Gold in a triangle

    The gold mining explorer Fokus Mining, which focuses on acquiring and exploring significant precious metal deposits in Quebec's province, is ideally positioned for the next wave. In August, it acquired a prime piece of property, the Galloway Project. The property is located in one of Canada's most productive mining regions. In the past 100 years, more than 100.0 million ounces of gold have already been produced from these deposits. The three main zones, GP, Hendrick and Moriss, form the so-called golden triangle. In addition to a fourth zone, Hund, these can be connected both on the surface and underground to form a corridor of over 1.7 kilometers.

    Ambitious plans

    With the conclusion of an equity financing of CAD 5.0 million in October, the stage was set for the next 40,000 meters of diamond drilling programs. As of today, six drill holes in the Moriss segment have been constructed and sent for assay. The CEO of Fokus Minerals Jean Rainville was delighted with the developments so far and expects to publish positive news steadily in the coming weeks and months. At the moment, the share price of Fokus Mining is at CAD 0.31. Due to the positive news flow, overcoming the all-time high of CAD 0.47 should not come as a surprise.

    Records upon records

    Monthly sales records are currently being delivered by the Chinese electric car manufacturer NIO. 7,007 vehicles were delivered in December alone, representing an increase of 121% compared to the same period last year. The star in the range, the six and seven-seater ES8, alone accounted for 2,009 units sold.

    NIO delivered 17,353 vehicles in the fourth quarter of 2020, an increase of 111% year-on-year and exceeding the Company's quarterly forecast's upper end. NIO's chairman believes the reasons for the outstanding success are the growing recognition of the premium brand, the competitive, compelling products and services, and the expanding distribution network.

    Expansive development

    The long-awaited sedan model is to be unveiled at the "NIO Day" on January 9, 2021. In addition, the ambitious competitor to Tesla and BYD plans to showcase the latest developments in its autonomous driving and other core technologies. The current share price is at USD 48.74. Breaking above the resistance zone at USD 50.0 would mean an end to the correction that has been ongoing since mid-November. The all-time high is at USD 57.20.

    Back to normal

    Unlike other sectors, tourism stocks knew only one direction in 2020: South. That could change soon. The CEO of TUI, Fritz Joussen, expects a reasonably normal summer. During the July and August holidays, it is likely that many flights on routes in the Mediterranean will be booked out quickly. As Joussen revealed to the "Rheinische Post," he even expects that the current vaccinations will make all travel restrictions unnecessary. We hope that the estimates of the TUI boss will prove to be true.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Stefan Feulner

    Stefan Feulner

    The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
    He is passionate about analyzing a wide variety of business models and investigating new trends.

    About the author



    Related comments:

    Commented by Carsten Mainitz on October 14th, 2026 | 05:30 CEST

    Tungsten, Weapons and Growth: Almonty, Rheinmetall and Deutz Under Review. Is This an Opportunity in a Megatrend?

    • Tungsten
    • Raw materials
    • Critical raw materials
    • Geopolitics
    • Defence industry
    • Armaments
    • Military
    • Supply chains
    • Investments

    The stock market is not linear. Greed and fear, excessive optimism or excessive scepticism—all of these drive markets. Only the future will tell what is cheap or expensive today. The stocks mentioned above are at precisely this point. Secure supply chains, access to raw materials and defence readiness are high on the agenda of Western governments. These long-term trends play strongly into the hands of defence companies and raw material producers. Almonty, in particular, as a producer of the critical raw material tungsten, holds a leading position in the sector. Where do the greatest opportunities lie for investors now?

    Read

    Commented by Carsten Mainitz on October 14th, 2026 | 05:25 CEST

    Who Profits When Patents Expire? The Billion-Euro Race Between Formycon, Fresenius and Pfizer

    • Biosimilar
    • FDA
    • Milestone
    • Cancer therapy
    • Pharma
    • Patents
    • Investments

    When patent protection for high-revenue biopharmaceuticals expires, a billion-euro market for follow-on products emerges. Michael Sen, head of the German healthcare group Fresenius SE, cites an impressive figure. By 2035, this could generate around EUR 180 billion in revenue. In particular, biosimilars, biotechnologically produced follow-on medicines that are highly similar in composition to the original medicine and equivalent in quality, efficacy and safety, are forecast to grow significantly. Moreover, biosimilars can strengthen competition and reduce treatment costs. Formycon stands out as a pure play. The company recently reached a crucial milestone. The US Food and Drug Administration (FDA) accepted the marketing authorisation application, the first publicly known application of its kind, for FYB206, a biosimilar candidate to the cancer medicine Keytruda, for review. Keytruda generates around USD 32 billion in annual revenue, making it the world's highest-revenue medicine. Fresenius is strengthening its positioning in the biosimilar sector through an acquisition. Pfizer needs new growth drivers. Who is best positioned for the year-end rally?

    Read

    Commented by Matthias Schomber on October 12th, 2026 | 05:24 CEST

    Every Crisis Creates an Opportunity: Nordex Stumbles, Jungheinrich Struggles, and RE Royalties Looks to Have Found a Bottom

    • Investments
    • Trading Opportunity
    • Technical Analysis
    • Rebound

    When market participants suddenly lose their nerve, and industrial heavyweights like Jungheinrich plunge to new multi-year lows despite bulging order books, a key question for private investors, among others, is whether this is a dangerous crisis with further downside ahead or an attractive entry opportunity. Nordex, too, has recently struggled to build on its successes from earlier this year. The share is trapped in a consolidation phase and has now returned to its level from late February, when it broke out upwards on high volume and with a long green weekly candlestick. Is this an attractive entry point for investors desperately seeking stable, high-yield alternatives in the future-oriented renewable energy market? Find out why scepticism could prevail regarding well-known German names and why a pioneer in royalty financing could be on the verge of the next major share price surge following a technical “textbook pattern”.

    Read